Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age20+
SponsorFar Eastern Memorial Hospital
About this trial
This study aims to compare intravenous chemotherapy versus intraperitoneal chemotherapy in patients with recurrent ovarian cancer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
women who had recurrent ovarian cancer and was treated with either intravenous or intraperitoneal platinum based chemotherapy
Disqualifiers
women who did not complete the designated treatment course (exception to those who had to quit due to progressive disease or death of any cause)
Trial population
woman with recurrent ovarian cancer who was treated with chemotherapy (either intravenous or intraperitoneal)
Trial design
Design model
Case-control
Time perspective
Retrospective
Treatments tested in this trial
Chemotherapy
DrugIntravenous chemotherapy versus intraperitoneal chemotherapy in recurrent ovarian cancer
Treatment groups
80 Participants
are divided into 2 treatment groupsGroup A: intravenous chemotherapy1 intervention
Group B: intraperitoneal chemotherapy1 intervention
Trial outcomes
Primary outcomes
1
RFS
Recurrence free survival
Time frame
the time interval from the date of surgery or the start of chemotherapy to clinically defined recurrence, disease progression, death from any cause or last follow-up2
OS
Overall Survival
Time frame
the time interval from the date of surgery or the start of chemotherapy to the date of death from any cause or last follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: